{"transactions":[{"id":1998436,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T01:00:40.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":8705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service."}],"balance_after":8705,"derivative":{"exercise_price":66.1,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":8705},"source":{"system":"sec-edgar","filing":"0000899243-23-005897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005897/doc4.xml","form_type":"4"}},{"id":1998435,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2023-02-23T01:00:40.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":5685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 5,685 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":5685,"source":{"system":"sec-edgar","filing":"0000899243-23-005897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924323005897/doc4.xml","form_type":"4"}},{"id":2083210,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":4740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":14063,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":4740},"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083209,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":18803,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083208,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":5947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":19053,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":5947},"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083207,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":4740,"price":58.96,"value":279470.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083206,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":4740,"price":38.46,"value":182300.4,"ownership":{"direct":true},"balance_after":4740,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083205,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":250,"price":60.02,"value":15005.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083204,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":250,"price":38.46,"value":9615.0,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083203,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":5947,"price":62.43,"value":371271.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2083202,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Common Stock","published_at":"2022-12-16T21:30:20.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":5947,"price":38.46,"value":228721.62,"ownership":{"direct":true},"balance_after":5947,"source":{"system":"sec-edgar","filing":"0000899243-22-038829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322038829/doc4.xml","form_type":"4"}},{"id":2373906,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T22:48:30.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026."}],"balance_after":38000,"derivative":{"exercise_price":13.28,"expiration_date":"2032-02-22","underlying":"Common\nStock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000899243-22-007683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924322007683/doc4.xml","form_type":"4"}},{"id":2828866,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:43:51.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":25000,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-008443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321008443/doc4.xml","form_type":"4"}},{"id":3221992,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T23:11:44.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":15000,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-007513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320007513/doc4.xml","form_type":"4"}},{"id":3444243,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":116583,"kind":"person","name":"DAMME LAURA","position":1,"cik":"0001784433","reported_name":"DAMME LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Affairs"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-07T22:01:12.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on the first anniversary of the vesting commencement date, August 1, 2019, and as to the remaining shares in equal monthly installments over three years thereafter."}],"balance_after":18000,"derivative":{"exercise_price":21.89,"expiration_date":"2029-08-05","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-19-021276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319021276/doc4.xml","form_type":"4"}}]}